Bullish Developments Continue; Downgrading Communications Bullish developments continue to flood the market, leading us to believe we may be in the early stages of a broad-based advance. • Bullish Arguments Flooding the Market. Major global and US indexes (SPY, RSP, QQQ, EEM, EFA, EUFN, ACWI, Europe, Japan, etc.) are making bullish inflections. Serial laggards such as retail (XRT) and biotech (IBB, XBI) appear to be bottoming. Cyclical Sectors are breaking topside resistance (e.g., XLK, XLF,...
Cautious outlook intact We continue expect additional consolidation, volatility, and potentially lower prices as the market attempts to stabilize. Important levels we are monitoring on the S&P 500 include support near 2,600 and resistance near 2,817 - which currently coincides with both the 100-day and 50-day moving averages. • Big picture trends. The growth (IUSG) vs. value (IUSV) uptrend is breaking down in favor of value -- shift exposure from growth to value. The large-cap (IVV) vs. smal...
S&P 500 at new all-time highs with uptrend intact Risk-on. The S&P 500 has surpassed the January all-time high, staying above this level for over a week. What's more important is the 5-month uptrend remains intact and cyclical/risk-on areas are reasserting their leadership status. Think technology, discretionary, and biotech/medical devices - all current overweights. At the same time, defensive areas have petered out in terms of relative strength, exactly what we want to see in a healthy bull m...
YTD S&P 500 trading range continues; Avoid broad international exposure Constructive but murky outlook for U.S. equities paints an overall mixed picture, making sector/group/stock selection critical. • Bull case: (1) advance-decline (A-D) lines and other breadth indicators (% of stocks above 50-, 200-day moving averages) are neutral to positive; (2) price and RS uptrends remain intact for risk-on segments, including Technology (XLK), biotech (XBI, IBB), and growth stocks (IUSG); and (3) the ...
Key Points: • We are upgrading Health Care to an overweight. XLV is breaking topside a bullish base and reversing a 9-month RS downtrend. • Biotechs are leadership and are breaking out of bullish consolidation. XBI and IBB are constructive and making positive inflections. • Energy remains a leadership Sector with many bullish bases that are still unexploited. We have highlighted a number of them in today's Vital Signs.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.